BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
Titel:
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
Auteur:
Hamy, A. S. Bieche, I. Lehmann-Che, J. Scott, V. Bertheau, Ph. Guinebretière, J. M. Matthieu, M. C. Sigal-Zafrani, B. Tembo, O. Marty, M. Asselain, B. Spyratos, F. Cremoux, P. de